Illumina, which specializes in DNA sequencing, will work on samples representing 1,300 species in the San Diego Zoo Wildlife ...

Illumina, Inc. (NASDAQ: ILMN) today announced a sequencing agreement with the San Diego Zoo Wildlife Alliance (SDZWA)'s ...

Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript February 5, 2026 Illumina, Inc. beats earnings expectations.

In early February 2026, Illumina reported past fourth-quarter 2025 revenue of US$1,159 million and net income of US$334 million, alongside full-year 2025 net income of US$850 million and new 2026 ...

A sequencing study conducted in Uganda reveals that one in four people has been exposed to a deadly hemorrhagic virus.

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

Illumina Inc (ILMN) reports a 5% revenue increase and a 42% rise in non-GAAP EPS, while navigating uncertainties in research funding and expanding its multiomics portfolio.

Total company revenue is projected at “$4.5 billion to $4.6 billion, representing reported growth of 4% to 6%,” with operating margins expected at 23.3% to 23.5% in 2026. EPS guidance is “$5.05 to ...

Investing.com -- Illumina Inc. (NASDAQ:ILMN) reported fourth-quarter earnings that beat analyst expectations, but shares ...

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.

In the prior quarter, Illumina delivered earnings of $1.34 per share, beating the $1.17 consensus by 14.5%, on revenue of $1.08 billion that topped estimates by nearly 1%. That performance was driven ...

Illumina () has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium. Unlock hedge fund-level data and powerful investing tools f ...